Fertility Preservation for Adolescent and Young Adult Women with cancer by means of Oocyte cryopreservatio
Not Applicable
Recruiting
- Conditions
- cancer patient, autoimmune disease patient
- Registration Number
- JPRN-UMIN000032034
- Lead Sponsor
- Hyogo College of Medicine College Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Informed Consent is not obtained
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation for a prospective advantage fertility preservation before cancer treatment Disadvantage is complications with the ovarian stimulation and oocyte pick up
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are affected by oocyte cryopreservation in cancer patients with autoimmune diseases?
How does oocyte cryopreservation compare to embryo cryopreservation for fertility preservation in adolescent oncology?
Which biomarkers predict successful oocyte cryopreservation outcomes in prepubertal or early-stage cancer patients?
What are the long-term safety profiles of gonadotropin stimulation protocols in young cancer patients undergoing oocyte cryopreservation?
How do cryoprotectant agents like ethylene glycol impact oocyte survival rates in vitrification-based fertility preservation?